Brenner Tumor Completed Phase 2 Trials for Sargramostim (DB00020)

Also known as: Brenner tumour

IndicationStatusPhase
DBCOND0000999 (Brenner Tumor)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00466960Sargramostim and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced Ovarian Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer That Did Not Respond to Previous ChemotherapyTreatment